Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PerkinElmer, Inc. PKI
$115.82
-$2.5 (-2.15%)
На 18:00, 12 мая 2023
+43.82%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
14654311100.00000000
-
week52high
170.00
-
week52low
113.46
-
Revenue
3311822000
-
P/E TTM
30
-
Beta
1.10242200
-
EPS
4.06000000
-
Last Dividend
0.28000000
-
Next Earnings Date
11 мая 2023 г. в 12:00
Описание компании
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stifel | Hold | Buy | 18 авг 2022 г. |
| B of A Securities | Neutral | Buy | 02 авг 2022 г. |
| Barclays | Underweight | Underweight | 02 авг 2022 г. |
| Baird | Outperform | Outperform | 02 авг 2022 г. |
| UBS | Buy | 20 июл 2022 г. | |
| Barclays | Underweight | Underweight | 12 сент 2022 г. |
| Credit Suisse | Neutral | 25 авг 2022 г. | |
| Barclays | Underweight | Underweight | 06 окт 2022 г. |
| Credit Suisse | Neutral | Neutral | 14 ноя 2022 г. |
| Cowen & Co. | Outperform | Market Perform | 06 дек 2022 г. |
| Barclays | Equal-Weight | Underweight | 28 ноя 2022 г. |
| Keybanc | Overweight | Sector Weight | 19 дек 2022 г. |
| Citigroup | Buy | Neutral | 12 дек 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Goldberg Joel S | D | 27319 | 1352 | 30 янв 2023 г. |
| Goldberg Joel S | D | 28671 | 4365 | 30 янв 2023 г. |
| Goldberg Joel S | A | 33036 | 12186 | 30 янв 2023 г. |
| Vohra Tajinder S | D | 21604 | 562 | 30 янв 2023 г. |
| Vohra Tajinder S | D | 22166 | 1657 | 30 янв 2023 г. |
| Vohra Tajinder S | A | 23823 | 6618 | 30 янв 2023 г. |
| Okun Andrew | D | 6398 | 2552 | 30 янв 2023 г. |
| Okun Andrew | D | 8950 | 2041 | 30 янв 2023 г. |
| Okun Andrew | A | 10991 | 4600 | 30 янв 2023 г. |
| Singh Prahlad R. | D | 68744 | 4829 | 30 янв 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3145770 | -24158 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 2290420 | -7042 | 31 авг 2020 г. |
| Vanguard Small-Cap Index Fund | 2768620 | -20480 | 31 июл 2020 г. |
| MFS Mid-Cap Growth Fund | 2143340 | 0 | 31 июл 2020 г. |
| Vanguard Small-Cap Value Index Fund | 1673760 | 600 | 31 июл 2020 г. |
| American Funds AMCAP Fund | 6664010 | 0 | 30 июн 2020 г. |
| T. Rowe Price Capital Appreciation Fund | 5895140 | -5281540 | 30 июн 2020 г. |
| American Funds Growth Fund of America | 2512810 | 765013 | 30 июн 2020 г. |
| Janus Henderson Enterprise Fund | 4426070 | 0 | 31 мар 2020 г. |
| Pictet-Security | 1225000 | 65000 | 29 февр 2020 г. |
Новостная лента
PerkinElmer (PKI) Q1 Earnings Surpass Estimates
Zacks Investment Research
11 мая 2023 г. в 08:24
PerkinElmer (PKI) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $2.41 per share a year ago.
Is a Surprise Coming for Revvity (PKI) This Earnings Season?
Zacks Investment Research
10 мая 2023 г. в 09:55
Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?
Zacks Investment Research
08 мая 2023 г. в 09:54
Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.
Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
28 апр 2023 г. в 13:39
PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PerkinElmer (PKI) Completes Divestment, New Business Name in Q2
Zacks Investment Research
14 мар 2023 г. в 09:58
PerkinElmer (PKI) completes separation of its businesses into two entities ??? the AES business, and the Life Sciences and Diagnostics business.